Scientists have discovered a unique drug combination that may stand a chance against a deadly child brain cancer. DIPG (diffuse intrinsic pontine glioma) is a lethal type of tumor that overwhelmingly affects children under the age of 12, and kills 99 percent of sufferers within five years. But despite more than 200 clinical trials, testing potent drugs that work on most other brain cancers, nothing has proved successful. Now, Stanford ...